Jean Macnamara’s Multiple Causes, 1931

The medical scientist made important contributions to polio treatment and Australian environmental policy—despite substantial resistance.

Written byCatherine Offord
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: PUBLIC HEALTH IMAGE LIBRARY

It was touch and go whether Jean Macnamara would be able to work at Melbourne’s Royal Children’s Hospital. When she sought employment there after graduating with a medical degree from the University of Melbourne in the early 1920s, hospital authorities were openly reluctant to hire a woman, telling Macnamara that there weren’t appropriate toilet facilities on the premises. Macnamara ended up getting the position, but it wouldn’t be the last time she faced resistance from the medical community.

A few years later, a polio epidemic hit Melbourne. The disease, which had been on the rise since the late 1800s and had recently caused a devastating outbreak in New York City, was notorious for its effect on children, who, in severe cases, died or were left paralyzed. At the time, not much was known about polio other than that it was a viral disease, says Gareth ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile

Published In

July/August 2020

Life During a Pandemic

Understanding the virus is just the beginning

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies